Roger Paredes

发表

Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations

Hezhao Ji, Rami Kantor, Santiago Ávila-Ríos, 2020, Viruses.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time

Peter M. A. Sloot, Matthias Assel, Anne-Mieke Vandamme, 2010, PloS one.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

Jan Albert, Kirsi Liitsola, Mario Poljak, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance.

Paul Sandstrom, Roger Paredes, Marc Noguera-Julian, 2017, The Journal of infectious diseases.

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

Klaus Korn, Kristof Theys, Anne-Mieke Vandamme, 2013, Retrovirology.

Viral Dynamics and In Vivo Fitness of HIV-1 in the Presence and Absence of Enfuvirtide

Sebastian Bonhoeffer, Rebecca Hoh, Roger Paredes, 2008, Journal of acquired immune deficiency syndromes.

2015 Update of the Drug Resistance Mutations in HIV-1.

Huldrych F Günthard, Vincent Calvez, Roger Paredes, 2015, Topics in antiviral medicine.

Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial

Roger Paredes, Esteban Martinez, Bonaventura Clotet, 2018, The Journal of antimicrobial chemotherapy.

Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients

Lidia Ruiz, Roger Paredes, Bonaventura Clotet, 2007, AIDS.

Quantitative Deep Sequencing Reveals Dynamic HIV-1 Escape and Large Population Shifts during CCR5 Antagonist Therapy In Vivo

James Theiler, Eoin Coakley, Bette Korber, 2009, PloS one.

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.

David Dunn, Kholoud Porter, Rodolphe Thiébaut, 2011, The Lancet. Infectious diseases.

Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.

Roger Paredes, Victoria A Johnson, Daniel R Kuritzkes, 2010, The Journal of infectious diseases.

2011 update of the drug resistance mutations in HIV-1.

Huldrych F Günthard, Vincent Calvez, Roger Paredes, 2011, Topics in antiviral medicine.

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects

Sarah Palmer, Roger Paredes, Viktor Dahl, 2010, Nature Medicine.